Advertisement
Screener

ENDRA LIFE SCIENCES INC. (NDRA) Increase Decrease In Operating Lease Liability

ENDRA LIFE SCIENCES INC. Increase Decrease In Operating Lease Liability

ENDRA LIFE SCIENCES INC. (NDRA) reported Increase Decrease In Operating Lease Liability of -$63.08 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14

  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$31.93K.
  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$31.15K, a 1179.96% decline year-over-year.
  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$32.98K.
  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$32.16K.
  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for fiscal 2025 was -$89.25K.
  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for fiscal 2024 was -$158.70K.
  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for fiscal 2023 was -$152.23K.
  • ENDRA LIFE SCIENCES INC. increase decrease in operating lease liability for fiscal 2022 was -$132.33K.
Period endIncrease Decrease In Operating Lease Liability 3 monthIncrease Decrease In Operating Lease Liability 6 monthIncrease Decrease In Operating Lease Liability 9 monthIncrease Decrease In Operating Lease Liability 12 month
2026-06-30-$31.93K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$63.08K
10-Q · filed 2026-08-14
-$96.06K
derived: sum of 3 quarters · filed 2026-08-14
-$128.22K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$31.15K
10-Q · filed 2026-05-15
-$64.12K
derived: sum of 2 quarters · filed 2026-05-15
-$96.29K
derived: sum of 3 quarters · filed 2026-05-15
-$123.28K
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$32.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$65.14K
derived: sum of 2 quarters · filed 2026-03-31
-$92.14K
derived: sum of 3 quarters · filed 2026-08-14
-$89.25K
10-K · filed 2026-03-31
2025-09-30-$32.16K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$59.16K
derived: sum of 2 quarters · filed 2026-08-14
-$56.27K
10-Q · filed 2025-11-14
-$86.22K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$27.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$24.11K
10-Q · filed 2026-08-14
-$54.05K
derived: sum of 3 quarters · filed 2026-08-14
-$98.05K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$2.88K
10-Q · filed 2026-05-15
-$27.06K
derived: sum of 2 quarters · filed 2026-05-15
-$71.05K
derived: sum of 3 quarters · filed 2026-05-15
-$113.96K
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31-$29.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$73.93K
derived: sum of 2 quarters · filed 2026-03-31
-$116.84K
derived: sum of 3 quarters · filed 2026-03-31
-$158.70K
10-K · filed 2026-03-31
2024-09-30-$43.99K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$86.90K
derived: sum of 2 quarters · filed 2025-11-14
-$128.76K
10-Q · filed 2025-11-14
-$168.61K
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30-$42.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$84.77K
10-Q · filed 2025-08-14
-$124.62K
derived: sum of 3 quarters · filed 2025-08-14
-$163.01K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$41.85K
10-Q · filed 2025-05-15
-$81.71K
derived: sum of 2 quarters · filed 2025-05-15
-$120.10K
derived: sum of 3 quarters · filed 2025-05-15
-$157.55K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$39.85K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07
-$78.25K
derived: sum of 2 quarters · filed 2025-04-07
-$115.70K
derived: sum of 3 quarters · filed 2025-04-07
-$152.23K
10-K/A · filed 2025-04-07
2023-09-30-$38.39K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21
-$75.84K
derived: sum of 2 quarters · filed 2024-11-21
-$112.37K
10-Q/A · filed 2024-11-21
-$147.06K
derived: sum of 4 quarters · filed 2024-11-21
2023-06-30-$37.45K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$73.98K
10-Q · filed 2024-08-14
-$108.66K
derived: sum of 3 quarters · filed 2024-08-14
-$142.03K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$36.53K
10-Q · filed 2024-05-14
-$71.21K
derived: sum of 2 quarters · filed 2024-05-14
-$104.58K
derived: sum of 3 quarters · filed 2024-05-14
-$137.12K
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$34.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$68.05K
derived: sum of 2 quarters · filed 2024-03-28
-$100.59K
derived: sum of 3 quarters · filed 2024-03-28
-$132.33K
10-K · filed 2024-03-28
2022-09-30-$33.36K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$65.91K
derived: sum of 2 quarters · filed 2023-11-14
-$97.65K
10-Q · filed 2023-11-14
-$127.70K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$32.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$64.28K
10-Q · filed 2023-08-14
-$94.33K
derived: sum of 3 quarters · filed 2023-08-14
-$123.19K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$31.74K
10-Q · filed 2023-05-15
-$61.79K
derived: sum of 2 quarters · filed 2023-05-15
-$90.65K
derived: sum of 3 quarters · filed 2023-05-15
-$115.21K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$30.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$58.91K
derived: sum of 2 quarters · filed 2023-03-16
-$83.47K
derived: sum of 3 quarters · filed 2023-03-16
-$100.34K
10-K · filed 2023-03-16
2021-09-30-$28.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$53.42K
derived: sum of 2 quarters · filed 2022-11-14
-$70.29K
10-Q · filed 2022-11-14
2021-06-30-$24.56K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$41.43K
10-Q · filed 2022-08-15
2021-03-31-$16.87K
10-Q · filed 2022-05-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRIDEX CORP (IRIX)United States$0.011B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B